National Healthcare Properties Amends $1.2B Credit Facility; Redeems Preferred

What Happened
National Healthcare Properties, Inc. filed an 8‑K (Aug 5, 2026) announcing an Amended and Restated Credit Agreement dated Aug 3, 2026 that establishes $1.2 billion of committed credit facilities, a planned redemption of all outstanding Series A and Series B preferred shares, and the Board’s election of Albert M. Campbell as a director effective Aug 10, 2026. The company also furnished a press release with its quarterly financial results for the quarter ended June 30, 2026.

Key Details

• Credit facilities: $1.2 billion total capacity comprised of a $750M senior unsecured revolving facility (up from $400M), a $300M senior unsecured term loan (up from $150M), and a new $150M delayed‑draw term loan. Revolver maturity: Aug 3, 2030; term and delayed‑draw maturities: Aug 3, 2029 (with limited extension options).
• Pricing & fees: Interest at base rate or SOFR plus margins that vary by leverage or credit ratings (SOFR margins roughly 0.65%–1.80% depending on conditions); facility fees on the revolver of 0.10%–0.35% depending on rating/leverage; 0.25% commitment fee on undrawn delayed‑draw after 90 days.
• Covenants & guarantees: Facilities are guaranteed by the parent and certain indirect subsidiaries and include customary covenants and quarterly financial maintenance tests (leverage, fixed charge coverage, tangible net worth, secured/unencumbered leverage, unsecured interest coverage) with a limited cure right.
• Preferred redemption & board change: The company elected to redeem all 3,289,061 Series A shares and 2,850,427 Series B shares, at $25.00 plus accrued dividends (total per‑share payments of $25.32 and $25.47). Redemption dates: Sept 4, 2026 (Series A) and Oct 6, 2026 (Series B). Notices were sent Aug 5 (A) and expected Aug 7 (B). Board: Albert M. Campbell (former MAA CFO) added and will join the Audit Committee.

Why It Matters

• Liquidity & flexibility: The larger revolver and new delayed‑draw facility expand the company’s near‑term borrowing capacity and optionality for working capital, acquisitions, refinancing and development spending. That can support growth or debt management but comes with customary covenants investors should monitor.
• Cost of capital & covenant oversight: Pricing tied to leverage or credit ratings means borrowing costs can change with the company’s financial profile. The quarterly maintenance covenants introduce metrics that could constrain actions if not met.
• Capital structure impact: Redeeming preferred shares will eliminate those dividend obligations and require roughly $155.9M in cash consideration (approx. $83.3M for Series A and $72.6M for Series B), reducing outstanding preferred equity but increasing near‑term cash outflow.
• Governance: Adding an experienced REIT CFO to the board and Audit Committee may strengthen financial oversight during a period of increased borrowing and capital activity.

(Press release with quarterly results was furnished as Exhibit 99.1 to the 8‑K; the 8‑K does not include detailed quarter financials beyond that filing.)